Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane channel-like protein 2 (TMC2) is an evolutionarily conserved membrane protein that functions as a probable pore-forming subunit of a mechanosensitive ion channel complex[2][3]. In vertebrates, TMC2 (alongside TMC1) is crucial for mechanotransduction in auditory hair cells, facilitating the conversion of sound-induced mechanical force into electrical signals required for hearing[3]. Structurally, TMC2 is a dimeric membrane protein with 10 transmembrane helices, and it complexes with auxiliary proteins such as TMIE and CALM-1[1][2]. It is widely expressed in sensory systems and is essential for normal auditory function, with mutations linked to hereditary hearing loss (though more direct links are established for TMC1). The gating and ion selectivity mechanisms, as well as downstream signaling, are the subject of extensive research, but the protein is considered a member of a novel ion channel family involved in fundamental sensory processes[2][3]. No clinically approved drugs are known to act on TMC2, and there are no established biomarkers or clinical safety concerns recognized to date[3].
Not established; no approved drugs directly target TMC2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane channel-like protein 2 (TMC2).